comparemela.com

Latest Breaking News On - Gland pharma q2 results - Page 1 : comparemela.com

Gland Pharma soars 5% on in-line Q2 results; should buy, hold or sell the stock?

Gland Pharma earnings have bottomed out and are on track to recovery with stable pricing and volume-led growth across geographies, said Jefferies.

Motilal oswalGland pharmaRocuronium bromideEnoxaparin sodiumMicafungin sodiumUpside scenarioGland pharma q2 earningsLand pharma q2 earnings newsAtest gland pharma q2 earnings updatesLand pharma q2 earnings latest newsLand pharma q2 earnings latest updatesLand pharma companies q2 earningsGland pharma q2 resultsLand pharma q2 results updatesLand pharma q2 results newsLand pharma latest q2 results updates

Gland Pharma Q2 results: Net Profit down 20% to Rs 194 crore

Gland Pharma had reported a 15.3 percent year-on-year (YoY) drop in net profit at Rs 194.1 crore for the first quarter ended June 30

Srinivas saduGland pharmaGland pharma q2 earningsGland pharma q2 resultsLand pharma q2 earnings updatesLand pharma q2 results updatesLand pharma quarterly resultsLand pharma q2 profitGland pharma share priceLand pharma stocks priceLand pharma share price updatesLand pharma stock price updatesGland pharma

Gland Pharma shares plunge 12% today: Should you buy, hold or sell?

Kotak said the near-term outlook for Gland Pharma is sluggish but the product pipeline and entry into new markets provide medium-term growth visibility.

Andhra pradeshUdayan mukherjeeMotilal oswalGland pharmaNirmal bang institutionalInstitutional equitiesIndus towersTata chemicalsHero motocorpGland pharma sharesGland pharma stock priceGland pharma share priceGland pharma q2 resultsGland pharma q2 earningsLand pharma earningsLand pharma results

Gland Pharma to announce four complex injectables during FY22; Q2 profit rises 38%

Announcing the Q2 FY22 financial results, CEO Srinivas Sadu stated that Gland Pharma is on track to make four complex injectable filing during the current financial year

Srinivas saduGland pharmaGland pharma complex injectablesGland pharma q2 resultsGland pharma profitGland pharma resultGland pharma shares

vimarsana © 2020. All Rights Reserved.